Company Filing History:
Years Active: 2007
Title: The Innovations of Benjamin Ward
Introduction
Benjamin Ward is a notable inventor based in Park City, Utah. He has made significant contributions to the field of genetics, particularly in relation to cancer predisposition. His work has implications for early detection and prevention strategies in breast and ovarian cancer.
Latest Patents
Ward holds a patent titled "Large deletions in human BRCA1 gene and use thereof." This patent addresses the identification of large deletions in the BRCA1 gene among patients. These genetic variants are linked to an increased risk of breast and ovarian cancer. The methods developed for detecting these variants are crucial for assessing cancer predisposition in individuals.
Career Highlights
Benjamin Ward is associated with Myriad Genetics, Inc., a company renowned for its focus on genetic testing and research. His work at Myriad Genetics has allowed him to contribute to advancements in genetic diagnostics and personalized medicine.
Collaborations
Ward has collaborated with esteemed colleagues such as Thomas M. Scholl and Brant C. Hendrickson. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of genetics.
Conclusion
Benjamin Ward's contributions to genetic research, particularly through his patent on the BRCA1 gene, highlight the importance of innovation in the fight against cancer. His work continues to influence the landscape of genetic testing and cancer prevention strategies.